Natus Medical Incorporated Announces Preliminary Revenue for the Second Quarter 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Natus Medical Incorporated (Nasdaq:BABY) today announced preliminary revenue for its second quarter ended June 30, 2013.

Revenue for the second quarter of 2013 is expected to be between $81 million and $82 million versus previous guidance of $86 million to $90 million.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC